Authors:
BALIS FM
HOLCENBERG JS
POPLACK DG
GE J
SATHER HN
MURPHY RF
AMES MM
WASKERWITZ MJ
TUBERGEN DG
ZIMM S
GILCHRIST GS
BLEYER WA
Citation: Fm. Balis et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF ORAL METHOTREXATE AND MERCAPTOPURINE IN CHILDREN WITH LOWER RISK ACUTE LYMPHOBLASTIC-LEUKEMIA - A JOINT CHILDRENS CANCER GROUP AND PEDIATRIC ONCOLOGY BRANCH STUDY, Blood, 92(10), 1998, pp. 3569-3577
Authors:
NOLL RB
MACLEAN WE
WHITT JK
KALEITA TA
STEHBENS JA
WASKERWITZ MJ
RUYMANN FB
HAMMOND GD
Citation: Rb. Noll et al., BEHAVIORAL-ADJUSTMENT AND SOCIAL FUNCTIONING OF LONG-TERM SURVIVORS OF CHILDHOOD LEUKEMIA - PARENT AND TEACHER REPORTS, Journal of pediatric psychology, 22(6), 1997, pp. 827-841
Authors:
BUCKLEY JD
BUCKLEY CM
RUCCIONE K
SATHER HN
WASKERWITZ MJ
WOODS WG
ROBISON LL
Citation: Jd. Buckley et al., EPIDEMIOLOGIC CHARACTERISTICS OF CHILDHOOD ACUTE LYMPHOCYTIC-LEUKEMIA- ANALYSIS BY IMMUNOPHENOTYPE, Leukemia, 8(5), 1994, pp. 856-864
Citation: Dg. Tubergen et al., BLASTS IN CSF WITH A NORMAL-CELL COUNT DO NOT JUSTIFY ALTERATION OF THERAPY FOR ACUTE LYMPHOBLASTIC-LEUKEMIA IN REMISSION - A CHILDRENS CANCER GROUP-STUDY, Journal of clinical oncology, 12(2), 1994, pp. 273-278
Citation: Gs. Gilchrist et al., LOW NUMBERS OF CSF BLASTS AT DIAGNOSIS DO NOT PREDICT FOR THE DEVELOPMENT OF CNS LEUKEMIA IN CHILDREN WITH INTERMEDIATE-RISK ACUTE LYMPHOBLASTIC-LEUKEMIA - A CHILDRENS CANCER GROUP-REPORT, Journal of clinical oncology, 12(12), 1994, pp. 2594-2600
Authors:
STEHBENS JA
MACLEAN WE
KALEITA TA
NOLL RB
SCHWARTZ E
CANTOR NL
WOODARD A
WHITT JK
WASKERWITZ MJ
RUYMANN FB
HAMMOND GD
Citation: Ja. Stehbens et al., EFFECTS OF CNS PROPHYLAXIS ON THE NEUROPSYCHOLOGICAL PERFORMANCE OF CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA - 9 MONTHS POSTDIAGNOSIS, Children's health care, 23(4), 1994, pp. 231-250
Authors:
SCHWANDA AE
FREYER DR
SANFILIPPO DJ
AXTELL RA
FAHNER JB
HACKBARTH RM
HASSAN NE
KOPEC JS
WASKERWITZ MJ
Citation: Ae. Schwanda et al., BRIEF UNCONSCIOUS SEDATION FOR PAINFUL PEDIATRIC ONCOLOGY PROCEDURES - INTRAVENOUS METHOHEXITAL WITH APPROPRIATE MONITORING IS SAFE AND EFFECTIVE, The American journal of pediatric hematology/oncology, 15(4), 1993, pp. 370-376